Sweden

Stayble Therapeutics BTA 230321 1

Not featured in screeners

Not featured in screeners

Insider activity signals

0 activity signals detected for Stayble Therapeutics BTA 230321 1

Insider trades have not triggered unusual activity signals for this company.

Top insiders

Download results Settings

2.4

Ulf Björklund Chairman of the Board of Directors Director

Transaction date 21 Apr 2023

Purchase

Price

297.97

Quantity 79,071

Value SEK2,795,098

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value	Details
2023-04-25	2023-04-21	B Purchase	2.4 Ulf Björklund Chairman of the Board of Directors Director	79,071 297.97 SEK2,795,098	79,071	297.97	SEK2,795,098

More insider trading research around Stayble Therapeutics BTA 230321 1